EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nomogram based on serum interleukin-33 levels and clinical characteristics for predicting overall survival in hematologic malignancy patients receiving haplo-HDPSCT

Gulisitan Aisikaer, Kaile Zhang, Ming Jiang

Annals of Hematology · 31.03.2026 · 105 (4)

DOI: 10.1007/s00277-026-06963-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 31.03.2026. Verfasst von Gulisitan Aisikaer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Center, Xinjiang Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Interleukin-33, Hematologic Neoplasms, Nomograms, Peripheral Blood Stem Cell Transplantation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation of China, Translational Research Grant of National Clinical Research Center for Hematologic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Hematologic NeoplasmsNomogramsPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHumansFemaleMaleMiddle AgedAdultPrognosisAdolescentSurvival RateYoung AdultNeoplasm, Residual

Stichwörter der Autor:innen

Haplo-HDPSCTIL-33MRDOS

Substanzen

Interleukin-33IL33 protein, human

Autor:innen und Institutionen

  • Hematology Center, Xinjiang Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Hematology Center, Xinjiang Institute of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. jiangmingyy@126.com.

Förderung

  • National Science Foundation of China
  • Translational Research Grant of National Clinical Research Center for Hematologic Diseases

Zitieren

APA

Aisikaer, G., Zhang, K., & Jiang, M. (2026). Nomogram based on serum interleukin-33 levels and clinical characteristics for predicting overall survival in hematologic malignancy patients receiving haplo-HDPSCT. Annals of Hematology, 105(4). https://doi.org/10.1007/s00277-026-06963-9

Vancouver

Aisikaer G, Zhang K, Jiang M. Nomogram based on serum interleukin-33 levels and clinical characteristics for predicting overall survival in hematologic malignancy patients receiving haplo-HDPSCT. Annals of Hematology. 2026;105(4). doi:10.1007/s00277-026-06963-9

BibTeX
@article{Aisikaer2026,
  author = {Aisikaer, Gulisitan and Zhang, Kaile and Jiang, Ming},
  title = {Nomogram based on serum interleukin-33 levels and clinical characteristics for predicting overall survival in hematologic malignancy patients receiving haplo-HDPSCT},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {4},
  doi = {10.1007/s00277-026-06963-9}
}
Kostenlos starten →